GlaxoSmithKline Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 600 | 0.000354% |
State or Government | 985,141 | 0.582% |
Institutions | 18,204,487 | 10.7% |
General Public | 23,161,282 | 13.7% |
Public Companies | 127,054,524 | 75% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
127,054,524 | ₹342.4b | 0% | no data | |||
2,726,172 | ₹7.3b | -16.8% | 0.05% | |||
2,157,098 | ₹5.8b | 0% | 0.1% | |||
2,115,160 | ₹5.7b | 0% | 1.99% | |||
1,751,731 | ₹4.7b | 0% | 0.12% | |||
1,711,233 | ₹4.6b | -11.1% | 0.25% | |||
1,541,996 | ₹4.2b | 38.7% | 0.15% | |||
1,151,961 | ₹3.1b | 0% | no data | |||
985,091 | ₹2.7b | -0.08% | no data | |||
985,000 | ₹2.7b | 14.5% | 0.31% | |||
813,149 | ₹2.2b | 0% | 0.03% | |||
763,270 | ₹2.1b | 2.62% | no data | |||
406,574 | ₹1.1b | 0% | 0.4% | |||
375,930 | ₹1.0b | 31.5% | 0.17% | |||
209,725 | ₹565.2m | 0% | no data | |||
198,146 | ₹534.0m | 2.53% | no data | |||
194,384 | ₹523.8m | 2,830% | 0.07% | |||
151,981 | ₹409.5m | 2.84% | 0.6% | |||
127,405 | ₹343.3m | -12.9% | 0.15% | |||
125,000 | ₹336.9m | 25% | 0.14% | |||
77,705 | ₹209.4m | 10.6% | no data | |||
67,248 | ₹181.2m | 205% | 0.01% | |||
66,071 | ₹178.0m | 0% | no data | |||
63,185 | ₹170.3m | 160% | 1.9% | |||
60,465 | ₹162.9m | 40.7% | no data |